SEC Filing Details

SEC Filing Details

Document Details

Form
SC 13D/A
Filing Date
Sep 1, 2009
Document Date
Sep 1, 2009
Form Description
An amendment to a SC 13D filing
Filing Group
Other
Company
ReShape Lifesciences
Issuer
Filer
Aberdare Ventures II, L.P.
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE